![Rachel Tsunemoto Hislop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rachel Tsunemoto Hislop is currently working as a Director at Abilita Therapeutics, Inc. and as a Principal at Two Bear Capital Operations LLC since 2020.
She completed her undergraduate degree from Massachusetts Institute of Technology.
| Sociétés | Poste | Début |
|---|---|---|
Two Bear Capital Operations LLC
 Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital invests in companies located in the United States and Canada. The firm target companies operating in the fields of biotechnology, healthcare IT, machine learning & AI, bioinformatics and information security. It provides financing for seed and early-stage capital requirements with an investment size of USD 3 - 10 million. It acts as a lead and co-lead investor and also takes a seat on the board of directors. | Private Equity Investor | 01/01/2020 |
Abilita Therapeutics, Inc.
 Abilita Therapeutics, Inc. BiotechnologyHealth Technology Operates as an innovation-driven biotechnology company focused on enabling discovery and development of drugs | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Abilita Therapeutics, Inc.
Abilita Therapeutics, Inc. BiotechnologyHealth Technology Operates as an innovation-driven biotechnology company focused on enabling discovery and development of drugs | Health Technology |
Two Bear Capital Operations LLC
Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital invests in companies located in the United States and Canada. The firm target companies operating in the fields of biotechnology, healthcare IT, machine learning & AI, bioinformatics and information security. It provides financing for seed and early-stage capital requirements with an investment size of USD 3 - 10 million. It acts as a lead and co-lead investor and also takes a seat on the board of directors. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
